| Authors: |
Mansell J; National Amyloidosis Centre, University College London, Royal Free Campus, Rowland Hill Street, NW3 2PF, London, UK., Wang X; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Jering KS; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Claggett B; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Zaroui A; Department of Cardiology, Referral Center for Cardiac Amyloidosis, Filiere Cardiogen, GRC Amyloid Research Institute all at APHP CHU Henri Mondor, Créteil, France., Ishizu T; Department of Cardiology, Institute of Medicine, University of Tsukuba, Japan., Eiros R; Cardiovascular Imaging Unit, Cardiology Department, University Hospital of Salamanca, Biomedical Research Institute of Salamanca, Spain., Jay PY; Alnylam Pharmaceuticals, Cambridge, MA., Cuddy SAM; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Abovich A; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Gillmore J; National Amyloidosis Centre, University College London, Royal Free Campus, Rowland Hill Street, NW3 2PF, London, UK., Solomon SD; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Fontana M; National Amyloidosis Centre, University College London, Royal Free Campus, Rowland Hill Street, NW3 2PF, London, UK. |
